Stock WXXWY WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Market Closed - OTC Markets
Other stock markets
 15:25:05 2024-06-07 EDT 		5-day change 1st Jan Change
2.813 USD -3.48% Intraday chart for WuXi Biologics (Cayman) Inc. -0.95% -62.24%
06-01 US lawmakers ask FBI for briefing on GenScript Biotech's links to China RE
05-31 US lawmakers ask FBI for briefing on GenScript Biotech's links to China RE

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors
AQ
WuXi facility boosts bioprocessing capacity with new bioreactors
AQ
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
RE
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
RE
China stocks rise as industrial profits grow; energy, semiconductor shares lead gains
RE
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%
MT
US House committee advances bill to restrict BGI, WuXi AppTec
RE
US House committee to vote on bill to restrict BGI, WuXi AppTec
RE
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms
MT
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling
DJ
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties
RE
Pacific Assets Trust cautiously optimistic after outpacing benchmark
AN
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment
PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024
AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories
AQ
Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer
CI
WuXi Biologics Reports Solid 2023 Annual Results
AQ
WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump
MT
WuXi Biologics 2023 Net Profit Fell on Higher Expenses, Impairment Losses
DJ
WuXi Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. WXXWY Stock
  5. News WuXi Biologics (Cayman) Inc.